Evidence map›Paper›PMID 38926341›Full record

ArticleNature communications2024

Solvent concentration at 50% protein unfolding may reform enzyme stability ranking and process window identification.

Frieda A Sorgenfrei, Jeremy J Sloan, Florian Weissensteiner, Marco Zechner, Niklas A Mehner, Thomas L Ellinghaus, Doreen Schachtschabel, Stefan Seemayer, Wolfgang Kroutil

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Frieda A SorgenfreiAustrian Centre of Industrial Biotechnology c/o University of Graz, Heinrichstrasse 28, 8010, Graz, Austria.ORCID 0000-0002-0690-7848
Jeremy J SloanBASF SE, Carl-Bosch-Strasse 38, 67056, Ludwigshafen, Germany.ORCID 0000-0001-7719-9407
Florian WeissensteinerAustrian Centre of Industrial Biotechnology c/o University of Graz, Heinrichstrasse 28, 8010, Graz, Austria.ORCID 0000-0001-7591-3443
Marco ZechnerAustrian Centre of Industrial Biotechnology c/o University of Graz, Heinrichstrasse 28, 8010, Graz, Austria.
Niklas A MehnerBASF SE, Carl-Bosch-Strasse 38, 67056, Ludwigshafen, Germany.ORCID 0009-0006-8868-9456
Thomas L EllinghausBASF SE, Carl-Bosch-Strasse 38, 67056, Ludwigshafen, Germany.ORCID 0000-0001-7629-9633
Doreen SchachtschabelBASF SE, Carl-Bosch-Strasse 38, 67056, Ludwigshafen, Germany.
Stefan SeemayerBASF SE, Carl-Bosch-Strasse 38, 67056, Ludwigshafen, Germany. stefan.seemayer@basf.com.
Wolfgang KroutilAustrian Centre of Industrial Biotechnology c/o University of Graz, Heinrichstrasse 28, 8010, Graz, Austria. wolfgang.kroutil@uni-graz.at.ORCID 0000-0002-2151-6394

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As water miscible organic co-solvents are often required for enzyme reactions to improve e.g., the solubility of the substrate in the aqueous medium, an enzyme is required which displays high stability in the presence of this co-solvent. Consequently, it is of utmost importance to identify the most suitable enzyme or the appropriate reaction conditions. Until now, the melting temperature is used in general as a measure for stability of enzymes. The experiments here show, that the melting temperature does not correlate to the activity observed in the presence of the solvent. As an alternative parameter, the concentration of the co-solvent at the point of 50% protein unfolding at a specific temperature T in short

Indexed as

Enzyme StabilityProtein UnfoldingSolventsOxidoreductasesTemperatureTransition TemperatureOxidoreductasesSolvents

Identifiers

PMID38926341
PMCPMC11208486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.